Mehmetoglu Esra, Mummadisetty Anvitha, Chatzittofis Andreas, Parperis Konstantinos, Sandorfi Nora, Derk Chris T
Istanbul Faculty of Medicine, Istanbul, Turkey.
Kakatiya Medical College, Warangal, India.
Clin Rheumatol. 2025 Apr 16. doi: 10.1007/s10067-025-07440-w.
This study aimed to investigate the prevalence of depression in Systemic Sclerosis (SSc) patients using depression self-assessment tools such as the Beck Depression Inventory (BDI), the Centre for Epidemiologic Studies Depression Scale (CES-D), and the Patient Health Questionnaire (PHQ-9) and to explore the clinical characteristics of SSc patients with depression and identify potential risk factors for depression.
Based on PRISMA guidelines, an electronic search was conducted in PubMed, Embase, PsycINFO, and Google Scholar to collect studies assessing systemic sclerosis and depression up to April 2024. Original research studies in SSc patients and depression using BDI > 10, CES-D > 16, and PHQ-9 > 10 that met our inclusion criteria were included and appraised using the Joanna Briggs Institute (JBI) instrument, then data extraction was performed.
We identified 497 articles, of which 22 were included in this systematic review. Among the 4,165 patients who completed the self-assessment questionnaires, 1486 (35.6%) met the criteria for depression where 564 (31.9%) of patients were identified based on the CES-D, 410 (55.1%) from the BDI, and 512 (30.8%) from the PHQ-9 group. Gastrointestinal involvement was the most identified predictor for depression, while pain, disease activity, and pulmonary and joint symptoms of SSc were also commonly associated with depression. Non-SSc-related predictors of depression included unemployment, low educational level, and unmarried status.
Higher prevalence of depression is seen among patients with SSc. Although the prevalence varies according to the assessment tool used, we found correlation of depression estimates in SSc-patients between the CES-D and PHQ-9 scores. Moreover, this review identifies the significant predictors of depression in SSc patients and highlights the need of mental healthcare professionals to engage in the care of SSc patients.
HB level was significantly related to disease activity and structural damage in RA patients. Key Points • There is significant variability in estimates of depression among different self-assessment questionnaires in patients with SSc. • We found correlation of depression estimates in SSc-patients between the CES-D and PHQ9 scores. • Among the studies reviewed strong predictors of depression in SSc-patients were identified. These were significant GI and arthritic manifestations, increased pain and disease severity, and a lower educational level. • Importance in engaging mental healthcare professionals in the care of SSc- patients as per our study up to a third of patients may benefit from this.
本研究旨在使用贝克抑郁量表(BDI)、流行病学研究中心抑郁量表(CES-D)和患者健康问卷(PHQ-9)等抑郁自评工具调查系统性硬化症(SSc)患者中抑郁症的患病率,探讨合并抑郁症的SSc患者的临床特征,并确定抑郁症的潜在危险因素。
根据PRISMA指南,在PubMed、Embase、PsycINFO和谷歌学术上进行电子检索,以收集截至2024年4月评估系统性硬化症和抑郁症的研究。纳入符合我们纳入标准的使用BDI>10、CES-D>16和PHQ-9>10评估SSc患者和抑郁症的原始研究,并使用乔安娜·布里格斯研究所(JBI)工具进行评估,然后进行数据提取。
我们识别出497篇文章,其中22篇纳入了本系统评价。在完成自评问卷的4165例患者中,1486例(35.6%)符合抑郁症标准,其中564例(31.9%)患者根据CES-D确定,410例(55.1%)来自BDI,512例(30.8%)来自PHQ-9组。胃肠道受累是最明确的抑郁症预测因素,而SSc的疼痛、疾病活动以及肺部和关节症状也常与抑郁症相关。抑郁症的非SSc相关预测因素包括失业、低教育水平和未婚状态。
SSc患者中抑郁症患病率较高。尽管患病率因所使用的评估工具而异,但我们发现CES-D和PHQ-9评分之间在SSc患者中抑郁症评估存在相关性。此外,本综述确定了SSc患者中抑郁症的重要预测因素,并强调了精神科医护人员参与SSc患者护理的必要性。
血红蛋白水平与类风湿关节炎患者的疾病活动和结构损伤显著相关。要点 • 在SSc患者中,不同自评问卷对抑郁症的评估存在显著差异。 • 我们发现CES-D和PHQ9评分在SSc患者中抑郁症评估存在相关性。 • 在纳入综述的研究中,确定了SSc患者抑郁症的强预测因素。这些因素包括显著的胃肠道和关节炎表现、疼痛加剧和疾病严重程度增加以及较低的教育水平。 • 根据我们的研究,精神科医护人员参与SSc患者护理很重要,多达三分之一的患者可能从中受益。